Journal

Journal of immunology (Baltimore, Md. : 1950)
ISSN: 1550-6606
Titre abrégé: J Immunol
Pays: United States
ID NLM: 2985117R

Informations de publication

Date de publication:
15 12 2019
Historique:
received: 23 07 2019
accepted: 04 10 2019
pubmed: 7 11 2019
medline: 27 5 2020
entrez: 8 11 2019
Statut: ppublish

Résumé

Formyl peptide receptor 2 (FPR2) is a G protein-coupled pattern recognition receptor sensing both mitochondrial- and bacterial-derived formylated peptides, including the PSMα toxins secreted by community-associated methicillin-resistant

Identifiants

pubmed: 31694908
pii: jimmunol.1900871
doi: 10.4049/jimmunol.1900871
doi:

Substances chimiques

Biomarkers 0
FPR2 protein, human 0
Reactive Oxygen Species 0
Receptors, Formyl Peptide 0
Receptors, Lipoxin 0
beta-Arrestins 0
NADPH Oxidases EC 1.6.3.-

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

3349-3360

Informations de copyright

Copyright © 2019 by The American Association of Immunologists, Inc.

Auteurs

Martina Sundqvist (M)

Department of Rheumatology and Inflammation Research, University of Gothenburg, Gothenburg, 413 46 Sweden.

Karin Christenson (K)

Department of Oral Microbiology and Immunology, Institute of Odontology, Sahlgrenska Academy, University of Gothenburg, Gothenburg, 405 30 Sweden.

Michael Gabl (M)

Department of Rheumatology and Inflammation Research, University of Gothenburg, Gothenburg, 413 46 Sweden.

André Holdfeldt (A)

Department of Rheumatology and Inflammation Research, University of Gothenburg, Gothenburg, 413 46 Sweden.

Karin Jennbacken (K)

Bioscience Cardiovascular, Research and Early Development, Cardiovascular, Renal and Metabolism, Biopharmaceuticals Research and Development, AstraZeneca, Gothenburg, 431 83 Sweden; and.

Thor C Møller (TC)

Department of Drug Design and Pharmacology, University of Copenhagen, Copenhagen, 2100 Denmark.

Claes Dahlgren (C)

Department of Rheumatology and Inflammation Research, University of Gothenburg, Gothenburg, 413 46 Sweden.

Huamei Forsman (H)

Department of Rheumatology and Inflammation Research, University of Gothenburg, Gothenburg, 413 46 Sweden; huamei.forsman@rheuma.gu.se.
Bioscience Cardiovascular, Research and Early Development, Cardiovascular, Renal and Metabolism, Biopharmaceuticals Research and Development, AstraZeneca, Gothenburg, 431 83 Sweden; and.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH